Read about the many ways Johnson & Johnson is working to #makeHIVhistory.
Innovation
Innovation-opedia: What Is a Mosaic Vaccine?
As the IAS Conference on HIV Science kicks off in Mexico City, we explain how an investigational HIV vaccine from the Janssen Pharmaceutical Companies of Johnson & Johnson works—and how researchers hope to help change lives around the world with it.
Today's Top Reads
Close
-
Did you like reading this story? Click the heart to show your love.
3172 -
Click the heart to show your support of this message.
733 -
Did you like reading this story? Click the heart to show your love.
227
More from Johnson & Johnson
July 06, 2020
As the International Aids Society Conference kicks off virtually this year, we sat down with three attendees, including activist and actress Laverne Cox, to talk about their groundbreaking work with HIV/AIDS in the midst of a global pandemic.
July 01, 2020
As the European Commission grants Marketing Authorization for the company's Ebola vaccine regimen—a key step towards enabling broader access to it for the people who need it most—we share top facts about the vaccine for the deadly virus.
June 29, 2020
From scientists working on a potential vaccine to medically trained employees who mobilized to the front lines to help treat patients, these men and women share what most resonates for them about the unique and devastating virus, both professionally and personally.
